This compound is a nitrosamine impurity of ciprofloxacin, characterized as a quinoline derivative with a carboxylic acid group and a piperazine ring. It serves as a reference standard for the quality control of ciprofloxacin in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Enrofloxacin
pharmaceutical raw material
Enrofloxacin hydrochloride
pharmaceutical raw material
Fluralaner
pharmaceutical raw material
Revefenacin
pharmaceutical raw material
Eluxadoline
pharmaceutical raw material
Сiprofloxacin hydrochloride
pharmaceutical raw material
Ciprofloxacin hydrochloride
pharmaceutical raw material
Ciprofloxacin lactate
pharmaceutical raw material
1-cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
ANFWNIUBWKCSEU-UHFFFAOYSA-N
C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCN(CC4)N=O)F)C(=O)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.